0001493152-15-002169.txt : 20150520 0001493152-15-002169.hdr.sgml : 20150520 20150520161850 ACCESSION NUMBER: 0001493152-15-002169 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150520 DATE AS OF CHANGE: 20150520 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Imprimis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-83793 FILM NUMBER: 15879834 BUSINESS ADDRESS: STREET 1: 12264 EL CAMINO REAL STREET 2: SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-704-4042 MAIL ADDRESS: STREET 1: 12264 EL CAMINO REAL STREET 2: SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Miloni Donald Paul CENTRAL INDEX KEY: 0001555960 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 1425 GREENWOOD LANE CITY: GREENWOOD VILLAGE STATE: CO ZIP: 80125 SC 13G/A 1 sc13ga.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

IMPRIMIS PHARMACEUTICALS, INC.

(Name of Issuer)

 

Common Stock, $0.001 par value

(Title of Class of Securities)

 

45323A 201

(CUSIP Number)

 

May 18, 2015

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  [  ] Rule 13d-1(b)
  [X] Rule 13d-1(c)
  [  ] Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 
 

 

CUSIP No. 45323A 201 13G Page 2 of 5 Pages

 

1. Names of Reporting Persons.
   
  Donald Miloni
   
2. Check the Appropriate Box if a Member of a Group (see instructions)
  (a) [  ]
  (b) [  ]
3. SEC Use Only
   
4

Citizenship or Place of Organization

   
  U.S.A

Number of Shares
Beneficially
Owned by
Each Reporting
 Person With:

5. Sole Voting Power

 

468,5761

 

6. Shared Voting Power

 

278,4792

 

7. Sole Dispositive Power

 

468,5761

 

8. Shared Dispositive Power

 

278,4792

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

 

747,0553

 
10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)

[  ]

 
11.

Percent of Class Represented by Amount in Row 9

 

7.82%4

 
12.

Type of Reporting Person (see instructions)

 

IN

 

 

 

1 Includes 468,576 shares of the Issuer’s common stock held in the name of the person filing this Schedule 13G.

 

2 Includes (i) 25,316 shares of the Issuer’s common stock held in the name of the spouse of the person filing this Schedule 13G, (ii) 151,898, shares of the Issuer’s common stock held in the name of 1425 Greenwood Lane, LLC, of which the person filing this Schedule 13G is a managing member, and (iii) 101,265 shares of the Issuer’s common stock held in the name of RCHER Financial, LLC, of which the person filing this Schedule 13G is a managing member.

 

3 Consists of the securities set forth in footnotes (1) and (2) above. The person filing this Schedule 13G disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

 

4 The percentage was calculated based on 9,511,026 shares of the Issuer’s common stock outstanding as of May 13, 2015.

 

 

 

2
 

 

CUSIP No. 45323A 201 13G Page 3 of 5 Pages

 

Item 1(a).

 Name of Issuer:

 

Imprimis Pharmaceuticals, Inc.

 

Item 1(b). Address of Issuer’s Principal Executive Offices:

 

12264 El Camino Real, Suite 350

San Diego, CA 92130

 

Item 2(a). Name of Person Filing:

 

Donald Miloni

 

Item 2(b). Address of Principal Business Office, or if None, Residence:

 

1425 Greenwood Lane

Greenwood Village, CO 80125

 

Item 2(c). Citizenship:

 

U.S.A.

 

Item 2(d). Title of Class of Securities:

 

Common Stock, par value $0.001

 

Item 2(e). CUSIP Number:

 

45323A 201

 

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

 

Not applicable

 

Item 4. Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a) Amount beneficially owned:

 

747,055*

 

  (b) Percent of class:

 

7.82%

 

  (c) Number of shares as to which such person has:

 

  (i) Sole power to vote or to direct the vote

 

468,576*

 

3
 

 

CUSIP No. 45323A 201 13G Page 4 of 5 Pages

 

  (ii) Shared power to vote or to direct the vote

 

278,479* (Includes (i) 25,316 shares of the Issuer’s common stock held in the name of the spouse of the person filing this Schedule 13G, (ii) 151,898, shares of the Issuer’s common stock held in the name of 1425 Greenwood Lane, LLC, of which the person filing this Schedule 13G is a managing member, and (iii) 101,265 shares of the Issuer’s common stock held in the name of RCHER Financial, LLC, of which the person filing this Schedule 13G is a managing member.)

 

  (iii) Sole power to dispose or to direct the disposition of

 

468,576*

 

  (iv) Shared power to dispose or to direct the disposition of

 

278,479* (Includes (i) 25,316 shares of the Issuer’s common stock held in the name of the spouse of the person filing this Schedule 13G, (ii) 151,898, shares of the Issuer’s common stock held in the name of 1425 Greenwood Lane, LLC, of which the person filing this Schedule 13G is a managing member, and (iii) 101,265 shares of the Issuer’s common stock held in the name of RCHER Financial, LLC, of which the person filing this Schedule 13G is a managing member.)

 

* The person filing this Schedule 13G disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

 

Item 5. Ownership of Five Percent or Less of a Class.

 

Not Applicable.

 

Item 6. Ownership of More Than Five Percent on Behalf of Another Person.

 

Not Applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

 

Not Applicable.

 

Item 8. Identification and Classification of Members of the Group.

 

Not Applicable.

 

Item 9. Notice of Dissolution of the Group.

 

Not Applicable.

 

Item 10. Certification.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

4
 

 

CUSIP No. 45323A 201 13G Page 5 of 5 Pages

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: May 20, 2015 DONALD MILONI
   
  By: /s/ Donald Miloni
    Donald Miloni, an individual

 

5